NP38625 Compounded Aseptic Medicines

A Contract Award Notice
by THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) (NSS)

Source
Find a Tender
Type
Contract (Supply)
Duration
3 year (est.)
Value
___
Sector
HEALTH
Published
23 Dec 2025
Delivery
To 22 Dec 2028 (est.)
Deadline
n/a

Related Terms

Location

All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014

Geochart for 2 buyers and 4 suppliers

2 buyers

1 supplier

Description

Supply of Compounded Aseptic Medicines to NHS Scotland.

Lot Division

1 Compounded Aseptic Medicines

The Authority intends to award this Lot as a single supplier framework. Molecules included within this Lot are as follows: CARBOPLATIN CETUXIMAB CYCLOPHOSPHAMIDE PEMBROLIZUMAB Full details of Goods and volumes can be found within the ITT documents.

Award Criteria
Product Stability 10.0
Communication 10.0
Capacity 10.0
Contingency 10.0
PRICE 60.0
2 Compounded Aseptic Medicines

The Authority intends to award this Lot as a single supplier framework. Molecules included within this Lot are as follows: EPIRUBICIN FLUOROURACIL IRINOTECAN METHOTREXATE NIVOLUMAB RITUXIMAB Full details of Goods and volumes can be found within the ITT documents.

Award Criteria
Product Stability 10.0
Communication 10.0
Capaccity 10.0
Contingency 10.0
PRICE 60.0
3 Compounded Aseptic Medicines

The Authority intends to award this Lot as a single supplier framework. Molecules included within this Lot are as follows: BORTEZOMIB CISPLATIN DOCETAXEL DOXORUBICIN GEMCITABINE INFLIXIMAB OXALIPLATIN TRASTUZUMAB VINCRISTINE Full details of Goods and volumes can be found within the ITT documents.

Award Criteria
Product Stability 10.0
Communication 10.0
Capacity 10.0
Contingency 10.0
PRICE 60.0
4 Compounded Aseptic Medicines

The Authority intends to award this Lot as an un-ranked multi supplier framework to a maximum of three (3) Framework Participants. Molecules included within this Lot are as follows: BEVACIZUMAB CYTARABINE FLUOROURACIL PRE-FILLED PUMPS INSULIN METHOTREXATE NATALIZUMAB PACLITAXEL PANITUMUMAB TRASTUZUMAB VEDOLIZUMAB Full details of Goods and volumes can be found within the ITT documents.

Award Criteria
Product Stability 10.0
Communication 10.0
Capacity 10.0
Contingency 10.0
PRICE 60.0

Award Detail

1 Unnamed (None)
  • Compounded Aseptic Medicines
  • Reference: n/a
  • CONTRACT NOT AWARDED – PROCUREMENT DISCONTINUED.
2 Unnamed (None)
  • Compounded Aseptic Medicines
  • Reference: n/a
  • CONTRACT NOT AWARDED – PROCUREMENT DISCONTINUED.
3 Unnamed (None)
  • Compounded Aseptic Medicines
  • Reference: n/a
  • CONTRACT NOT AWARDED – PROCUREMENT DISCONTINUED.
4 Unnamed (None)
  • Compounded Aseptic Medicines
  • Reference: n/a
  • CONTRACT NOT AWARDED – PROCUREMENT DISCONTINUED.

CPV Codes

  • 33600000 - Pharmaceutical products

Indicators

  • Award on basis of price.

Other Information

The estimated value(s) referred to in Section II.1.5 and within all Lots cover(s) the thirty-six (36) month contract duration and the twelve (12) month extension period of the framework agreement. (SC Ref:819359)

Reference

  • FTS 085742-2025

Domains